BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan Q, Zuo J, Tian H, Huang C, Nice EC, Shi Z, Kong Q. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells. J Exp Clin Cancer Res 2022;41:162. [PMID: 35501823 DOI: 10.1186/s13046-022-02372-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Lu W, Yang Y, Xiang R, Ling Y, Yu C, Zhou Y. Hybrid Nanomaterials for Cancer Immunotherapy. Adv Sci (Weinh) 2022;:e2204932. [PMID: 36567305 DOI: 10.1002/advs.202204932] [Reference Citation Analysis]
2 Wang Y, He C, Chen C, Dong W, Yang X, Wu Y, Kong Q, Yan B. Thermoresponsive Self-Healing Zwitterionic Hydrogel as an In Situ Gelling Wound Dressing for Rapid Wound Healing. ACS Appl Mater Interfaces 2022;14:55342-53. [PMID: 36473731 DOI: 10.1021/acsami.2c15820] [Reference Citation Analysis]
3 Lu S, Tian H, Li L, Li B, Yang M, Zhou L, Jiang H, Li Q, Wang W, Nice EC, Xie N, Huang C, Liu L. Nanoengineering a Zeolitic Imidazolate Framework-8 Capable of Manipulating Energy Metabolism against Cancer Chemo-Phototherapy Resistance. Small 2022;18:e2204926. [PMID: 36260824 DOI: 10.1002/smll.202204926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xia Y, Wang D, Piao Y, Chen M, Wang D, Jiang Z, Liu B. Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1025532] [Reference Citation Analysis]
5 Xie H, Liu X, Huang Z, Xu L, Bai R, He F, Wang M, Han L, Bao Z, Wu Y, Xie C, Gong Y. Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects. Cancers 2022;14:3935. [DOI: 10.3390/cancers14163935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jiang ZY, Liu JB, Wang XF, Ma YS, Fu D. Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221124696. [PMID: 36128851 DOI: 10.1177/15330338221124696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]